• 목록
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There aren't many studies on how exposure to ADHD for a long time could affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological developmental conditions like impaired vision or hearing seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should consider the benefits of taking it versus the dangers for the foetus. Physicians do not have the information needed to give clear guidelines but they can provide information regarding the risks and benefits to assist pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based study of case-control to assess the risk of major structural birth defects in babies born to mothers who had taken stimulants in early pregnancy and those who had not. Clinical geneticists and pediatric cardiologists examined the cases to ensure accurate classification of the cases and to reduce the chance of bias.

The research conducted by the researchers was not without its limitations. The most important issue was that they were not able to differentiate the effects of the medication from the effects of the disorder at hand. This makes it difficult for researchers to determine whether the small associations observed among the exposed groups were due to the use of medications, or if they were caused by the presence of comorbidities. In addition, the researchers did not look at long-term offspring outcomes.

The study did show that infants whose mothers took adhd medication names uk medications during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or taken off their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medication during pregnancies in the early stages could be offset by the more beneficial outcomes for both baby and mother of continued treatment for the woman's disorder. Physicians should speak with their patients about this issue and as much as possible, assist them develop coping strategies that may reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the issue of whether or not to discontinue treatment during pregnancy is a question that more and more physicians face. Often, these decisions are taken in the absence of any evidence that is clear and definitive regardless, so doctors must weigh what they know, the experiences of other doctors, and what research suggests on the subject as well as their best judgment for each individual patient.

The issue of risk to infants is particularly tricky. The research on this issue is based on observation rather than controlled studies and many of the findings are in conflict. Most studies focus on live births, which can underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these issues, by examining both data on live and deceased births.

Conclusion: While some studies have revealed an association between ADHD medications and certain birth defects However, other studies haven't established a link. Most studies have shown an unintended, or somewhat negative, effect. As a result, a careful risk/benefit analysis must be conducted in every case.

For women suffering from ADHD, the decision to stop taking medication is difficult, if not impossible. In an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation and family conflict for patients with ADHD. A decrease in medication could also affect the ability to drive safely and perform work-related tasks, which are essential aspects of daily life for those suffering from ADHD.

She suggests that women who are unsure about whether to continue or discontinue medication due to their pregnancy, consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily life, and the advantages of continuing the current treatment regimen. It can also help women feel more confident in her decision. Some medications can pass through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it's important to be aware that the medication could be passed on to her baby.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about the effects that the medications could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. Researchers utilized two massive data sets to examine over 4.3 million pregnancies and determine if stimulant medication use increased birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medications was associated with an increased risk of specific heart defects, such as ventriculo-septal defect (VSD).

The researchers behind the study found no connection between the use of early medications and other congenital abnormalities, like facial clefting, or club foot. The results are in line with previous studies that have shown a small but significant increase in the risk of cardiac malformations among women who started taking adhd medication pregnancy medications prior to the birth of their child. This risk increased during the latter stages of pregnancy when a large number of women began to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean delivery and also have an insufficient Apgar after birth and have a baby that needed breathing assistance when they were born. The researchers of the study were not able to eliminate selection bias because they restricted the study to women with no other medical conditions that might have contributed to the findings.

The researchers hope their study will help inform the clinical decisions of doctors who encounter pregnant women. The researchers suggest that while discussing risks and benefits are important, the decision about whether to continue or stop medication should be according to the severity of each woman's ADHD symptoms and the needs of the woman.

The authors caution that, while stopping the medication is an option to think about, it isn't advised because of the high incidence of depression and other mental disorders among women who are pregnant or who have recently given birth. Further, the research suggests that women who decide to stop taking their medications are more likely to experience a difficult time adjusting to life without them after the birth of their baby.

Nursing

It can be a stressful experience to become a mom. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments as well as preparing for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. Many women decide to continue taking their ADHD medication during pregnancy.

The risk to a nursing infant is low because the majority of stimulant medications is absorbed through breast milk in low amounts. However, the amount of exposure to medication by the infant can differ based on dosage, how often it is taken and the time of day it is administered. In addition, various medications are introduced into the baby's system via the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn isn't completely comprehended.

Because of the lack of evidence, some doctors may recommend stopping stimulant medications during a woman's pregnancy. This is a difficult decision for the mother, who must weigh the advantages of continuing her medication against the risk to the fetus. As long as more information is available, doctors can inquire about pregnant patients if they have a background of ADHD or if they intend to take medication in the perinatal stage.

A growing number of studies have shown that the majority of women are able to safely continue to take their ADHD medication while they are pregnant and nursing. In the end, many patients are choosing to do so and, after consulting with their doctor, they have discovered that the benefits of continuing their current medication exceed any risk.

It is essential for women with adhd Medication pregnancy who are contemplating breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with prescribe adhd medication recognize the signs and underlying disorder. They should also be informed about treatment options and strengthen coping mechanisms. This should include a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration, and, if necessary adjustments to the medication regime.